Tounjian Advisory Partners »

Zenas Biopharma shares owned by Tounjian Advisory Partners

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Tounjian Advisory Partners from 13F filings

Historical chart of Tounjian Advisory Partners investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Tounjian Advisory Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Tounjian Advisory Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $64k 2.5k 25.38

More positions owned by Tounjian Advisory Partners

First Tr Exchange-traded Growth Strength (FTGS)
First Tr Exchng Traded Fd Vi Ft Ladd Buff Etf (BUFR)
Apple (AAPL)
Innovator Etfs Trust Us Eqty Ultra B (UDEC)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ge Aerospace Com New (GE)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Tesla Motors (TSLA)
First Tr Exchange-traded Indxx Aerospace (MISL)
Cisco Systems (CSCO)
Home Depot (HD)
Wal-Mart Stores (WMT)
Boeing Company (BA)

View all positions for Tounjian Advisory Partners

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma